Alison co-heads our international Life Sciences and Healthcare group. She works with international life sciences companies to cut through the complexity of EU regulation of medical devices and pharmaceuticals, and get their products to market.

In a career of over 20 years, Alison has helped hundreds of life sciences companies manage the range of legal challenges involved in commercialising medical devices and medicinal products. She combines an encyclopaedic knowledge of the EU and UK life sciences regulatory environment with an analytical understanding of strategy and business in the life sciences sector. 

Alison provides sophisticated advice on regulation, compliance and commercialisation, as well as intellectual property transactions. On a number of occasions, she has successfully persuaded regulators and notified bodies to reconsider and ultimately overturn their decisions, allowing her clients to commercialise new products.

Alison supports clients on outright acquisitions and licences, as well as in due diligence for sizeable corporate transactions and listings. She also helps clients navigate the nuances of structuring and negotiating arrangements with various commercial and health care partners within the complex framework of EU regulations, national laws and industry and deontological codes. 

Her clients praise the pragmatism and commercial awareness she brings to every legal challenge and transaction, as well as her bright and personable working style. She is an accomplished leader, having built new life sciences practices for two top-tier London law firms.

显示完整简历 隐藏完整简历



Defining artificial intelligence (AI) and why it matters for medical device regulation


作者 Alison Dennis


Issues with regulation of telemedicine in the UK

In-depth analysis

作者 Alison Dennis 以及 Sarah Parkin


Digital health in the metaverse: legal and regulatory challenges in the virtual world

In-depth analysis

作者 Alison Dennis 以及 Alice Matthews


Alison Dennis and Saleem Fazal recognised in The Lawyer's Hot 100 for 2022